- •Canine cutaneous T-cell lymphoma (CTCL) has the potential to be used as a model animal for human primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma (CD8+PCECTL).
- •A novel canine CTCL cell line, termed EO-1, was established from a dog with CTCL.
- •EO-1 expressed CD3 and CD8 with a high expression of a functional CC chemokine receptor 4 that was biologically active to both human and mouse CCL17/TARC.
- •EO-1 may be a useful tool in the research for not only canine CTCL but also human CD8+PCECTL.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
- A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.Vet. Pathol. 2010; 47: 414-433
- Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.Am. J. Pathol. 1994; 144: 421-429
- Gene transcription analysis in lesional skin of canine epitheliotropic cutaneous lymphoma using quantitative real-time RT-PCR.Vet. Immunol. Immunopathol. 2011; 144: 329-336
- Canine cutaneous epitheliotropic T-cell lymphoma: a review of 30 cases.Vet. Dermatol. 2010; 21: 267-275
- Increased CCR4 expression in cutaneous T cell lymphoma.J. Invest. Dermatol. 2002; 119: 1405-1410
- The chemokine receptor CCR4 in vascular recognition by cutaneous but not intestinal memory T cells.Nature. 1999; 400: 776-780
- Expression and function of FRA2/JUND in cutaneous T-cell lymphomas.Anticancer Res. 2012; 32: 1367-1373
- Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia.Oncogene. 2008; 27: 3221-3232